Abstract:
Disclosed are devices and methods for treating disease in a urinary bladder. The devices include a bladder liner for insertion into the urinary bladder and catheters positioned within the urinary bladder to carry urine from the ureters to an outside collection container. The bladder liner and catheters are constructed of biocompatible materials and are configured to create a seal with the urethra and ureters. The bladder liner may be adapted to deliver medicinal agents to the urinary bladder. Methods of treating disease in the urinary bladder include isolating urine from the bladder wall to allow sufficient time for the bladder wall to heal e.g., by implanting the aforementioned devices. Healing or pain relief may be enhanced by instilling pharmaceutical agents between the liner and bladder wall without dilutional effects.

Description:
CROSS-REFERENCE TO RELATED APPLICATION 
     This application incorporates by reference, and claims priority to and the benefit of, U.S. Provisional Patent Application Ser. No. 60/233,881, which was filed on Sep. 20, 2000. 
    
    
     TECHNICAL FIELD 
     The invention generally relates to treating a urinary bladder. 
     BACKGROUND 
     Interstitial cystitis (IC) is a chronic inflammation or irritation of the urinary bladder wall that is estimated to affect between 500,000 and 1,000,000 people in the U.S. (approximately 90% female). The primary symptoms of IC are urinary urgency, frequency, and often-severe pelvic and perineal pain. The similarity of the symptoms of IC with other bladder diseases, such as urinary tract infections (UTI), urethritis, urethral syndrome, trigonitis, prostatitis, dysuria, and nocturia has caused difficulty in the diagnosis of the disease. After other similar bladder diseases are ruled out and a cystoscopic examination of the bladder wall reveals characteristic signs of IC, including small petechial hemorrhages or larger Hunner&#39;s Ulcers, IC is usually diagnosed. 
     The biological cause of IC remains undetermined. The theory that IC is caused by a bacterial infection is controversial. IC patients routinely test negative for infection in standard urinalysis. On the other hand, several studies have shown antibiotic treatment regimens to alleviate symptoms for IC patients. Another possible cause is a defect in the epithelial permeability barrier of the bladder surface glycosaminoglycans (GAG). Once the bladder wall loses the protective coating of GAG, irritative components and potentially pathogenic bacteria in the urine can lead to the inflammation or irritation associated with IC. Another line of research indicates that activated mast cells, which are associated with pain and irritation, are involved in the pathology of IC. Studies have shown that IC patients have an increased level of activated mast cells in the tissues of the bladder wall. 
     Currently there is no permanent cure for IC in the majority of patients. Treatment of IC with drug therapy has been proven to be the most effective means of alleviating symptoms. Oral medications for IC include bladder-coating agents, antidepressants, antihistamines, antispasmodics, and anesthetics. The effectiveness of oral medications is limited by the circulating concentration of the drug in the blood stream. To address this limitation, many IC patients elect to undergo a procedure called urinary bladder instillation, in which a therapeutic solution is pumped into the bladder through a urethral catheter. The solution, which may be composed of one or a combination of medications, is held in the bladder for a “dwell time” before the bladder is drained or voided. This procedure allows the treatment of the urinary bladder wall directly with high concentrations of medicine. Despite the drawbacks of a limited dwell time for the medication to take effect and the necessary mixture of medication with urine, bladder instillation may be the most effective treatment currently available for IC. 
     SUMMARY OF THE INVENTION 
     The current urinary bladder instillation procedure for IC patients can be made more effective by increasing the dwell time and/or by using medication undiluted by urine. The invention generally relates to devices and ways for increasing dwell time in bladder instillations and/or for preventing dilution of the medication(s) used in bladder instillations. 
     Generally, the invention can feature a device for substantially isolating urine from the urinary bladder wall to give the bladder mucosal layer sufficient time to heal. The device can include a bladder, liner, or sack designed to fit inside the urinary bladder. The liner functions as an inner bladder for the urinary bladder and serves to protect the urinary bladder wall from contacting urine. Preventing urine from contacting the urinary bladder wall serves multiple therapeutic purposes. First, it allows the urinary bladder wall to be treated with medications without the medications being diluted by urine. Second, because the medications applied to the urinary bladder wall are prevented from mixing with the urine, they are not flushed out of the body following the voiding of the bladder. Third, the urinary bladder wall is protected from the caustic nature of the urine allowing for a more rapid healing process. 
     In general, the invention also can feature a system of catheters that connect to the ureteral orifices proximal to the urinary bladder and convey urine to an exterior urine collection bag or container. This device would provide similar therapeutic benefits as the urinary bladder liner by preventing urine from collecting in the urinary bladder or contacting the urinary bladder wall in any significant quantity. This device generally uses an external urine collection container to collect any urine flow resulting from the urinary bladder by-pass. 
     In one aspect, the invention relates to a medical device including a urinary bladder liner. The liner is adapted to fit within a patient&#39;s urinary bladder. The liner has a reservoir and two inlet orifices that are adapted to sealably connect to respective ends of the patient&#39;s ureters and an outlet orifice adapted to extend into the patient&#39;s urethra. The liner isolates urine from the urinary bladder. In various embodiments of the invention, the outlet orifice is adapted to sealably connect to the urethra and/or extend through the urinary sphincter and/or connect to a catheter that extends through the urinary sphincter. In other embodiments of the invention, the inlet orifices are connected to catheters that are adapted to sealably connect to the respective ureter openings. Alternatively, the catheters are adapted to extend through the patient&#39;s ureters and into the patient&#39;s kidneys. The distal ends of the inlet catheters may be coiled to fit in a kidney basin. The inlet catheters may include a plurality of fins mounted on exterior surfaces of the catheters and adapted to form a liquid-impermeable seal with a wall of each ureter. 
     In further embodiments, the outlet orifice or outlet catheter is made of a material sufficiently flexible so that the orifice or catheter can be completely compressed by the urinary sphincter. In addition, the sealable connections can be made with a biocompatible adhesive. Alternatively, the sealable connections can be created by the expansion of an outer wall diameter of an end of the catheter that contacts the body, which functions to fix the catheter end in place and to form a liquid-impermeable seal. In addition, the liner can be made of a pliant material, and/or a material chosen from silicone, vinyl, polyethylene, PVC, latex, ethylene vinyl acetate, and polypropylene, and/or a material that stretches and shrinks. Also, the liner can be coated with a heparin-like drug or a slippery material, such as a hydrogel, on the outer surface. 
     In yet another aspect, the invention relates to an apparatus for isolating urine from a patient&#39;s urinary bladder. The apparatus includes a first catheter and a second catheter, each including a proximal and a distal end. The proximal ends of the first and second catheters are adapted to sealably connect to the patient&#39;s ureter walls. The distal ends of the first and second catheters pass through the patient&#39;s urinary sphincter. Alternatively, the first and second catheters may each pass through a suprapubic incision in the patient&#39;s abdominal wall. The apparatus also includes an external urine collection container that is connected to the distal ends of the first and second catheters. In one embodiment, the first and second catheters include valves disposed between the distal ends of the catheters and either a distal end of the patient&#39;s urethra or the suprapubic incisions. The valves control the flow of urine to the collection container. 
     In one embodiment, the first and second catheters are joined together to form a third catheter. A proximal end of the third catheter is connected to and joins the distal ends of the first and second catheters. The distal end of the third catheter passes through the patient&#39;s urinary sphincter. Alternatively, the third catheter may pass through a suprapubic incision in the patient&#39;s abdominal wall. An external urine collection container is connected to a distal end of the third catheter. In some embodiments, the third catheter includes a valve disposed between either a distal end of a urethra or the suprapubic incision and the distal end of the third catheter for controlling the flow of urine to the collection container. In some embodiments, the seals are composed of biocompatible adhesives and/or the catheters are composed of materials comprising biocompatible plastics. In addition, the catheters can be made of materials chosen from silicone, vinyl, polyethylene, PVC, latex, ethylene vinyl acetate, and polypropylene. 
     In still another aspect, the invention relates to a method of treating urinary bladder diseases. The method includes the steps of isolating urine from a urinary bladder and treating the urinary bladder with appropriate medications. Appropriate medications include oral medications and/or topical medications. Typically, topical medications are instilled between a wall of the bladder and the bladder liner. The step of isolating the urine from the urinary bladder includes inserting a urinary bladder liner into the bladder. In another method, the step of isolating urine from the urinary bladder includes inserting an apparatus that carries urine from the ureter orifices to an external urine collection container. In one embodiment, the apparatus exits the patient&#39;s body through the urinary sphincter. In another embodiment, the apparatus exits the patient&#39;s body through one or more suprapubic incisions through the patient&#39;s abdominal wall. 
     These and other objects, along with advantages and features of the present invention herein disclosed, will become apparent through reference to the following description of embodiments of the invention, the accompanying drawings, and the claims. Furthermore, it is to be understood that the features of the various embodiments described herein are not mutually exclusive and can exist in various combinations and permutations. 
    
    
     BRIEF DESCRIPTION OF THE DRAWINGS 
     In the drawings, like reference characters generally refer to the same parts throughout the different views. Also, the drawings are not necessarily to scale, emphasis instead generally being placed upon illustrating the principles of the invention. In the following description, various embodiments of the present invention are described with reference to the following drawings. 
     FIG. 1 is a depiction of a bladder liner that is designed to fit inside a patient&#39;s urinary bladder. The bladder liner possesses three orifices, two of which are positioned to interface with the patient&#39;s two ureters. The material of the bladder liner at the two inlet orifices extends into the orifice of the ureter and is fixed in place by a sealant. The outlet orifice of the bladder liner is the outlet tube that extends into the patient&#39;s urethra. This device provides for urinary continence by maintaining sphincter function. 
     FIG. 2 is a depiction of a bladder liner that is designed to fit inside a patient&#39;s urinary bladder. Three catheters lead from the bladder liner. The two catheters that are situated on one side of the bladder liner are sealed to the patient&#39;s two ureters. The third catheter, which is generally situated on the opposite side of the bladder liner, extends into the patient&#39;s urethra past the urinary sphincter. This device provides for patient continence by maintaining sphincter function. 
     FIG. 3 is a depiction of a bladder liner that is designed to fit inside a patient&#39;s urinary bladder. Three catheters lead from the bladder liner. The two catheters that are situated on one side of the bladder liner are sealed to the patient&#39;s two ureters. The third catheter, which is generally situated on the opposite side of the bladder liner, is sealed to the patient&#39;s urethra so as not to extend past the urinary sphincter. This device provides for patient continence by maintaining sphincter function. 
     FIG. 4 is a depiction of a bladder liner that is designed to fit inside a patient&#39;s urinary bladder. Three catheters lead from the bladder liner. The two catheters that are situated on one side of the bladder liner are inserted into the patient&#39;s two ureters. The two catheters inserted in the ureters expand to the diameter of the ureter forming a strong and fluid-impervious junction. The third catheter, which is generally situated on the opposite side of the bladder liner, extends into the patient&#39;s urethra past the urinary sphincter. This device provides for patient continence by maintaining sphincter function. 
     FIG. 5 a  is a depiction of a bladder liner that is designed to fit inside a patient&#39;s urinary bladder. Three catheters lead from the bladder liner. The two catheters that are situated on one side of the bladder liner extend into the patient&#39;s two ureters and continue up and into the kidneys, where the catheters coil into a pigtail formation that prevents migration of the catheters out of the kidney. The third catheter, which is generally situated on the opposite side of the bladder liner, extends into the patient&#39;s urethra past the urinary sphincter. This device provides for patient continence by maintaining sphincter function. 
     FIG. 5 b  is a depiction of a coiled end of the catheters of FIG. 5 a  that reside in the kidney. The pigtail portion of the catheter prevents the migration of the catheters down the ureter and into the urinary bladder. Fins or seals on the exterior surfaces of the catheters prevent flow of urine down the ureter and force the urine flow into the catheters. 
     FIG. 6 is a depiction of a catheter device that is designed to fit inside a patient&#39;s urinary bladder. Two catheters are sealed to the patient&#39;s two ureters and extend through the urinary bladder and the urethra to the outside of the patient&#39;s body where both catheters empty into an external urine container. A shutoff valve prevents the flow of urine from one or both catheters. Normal sphincter function is lost with this device. 
     FIG. 7 is a depiction of a catheter device that is designed to fit inside a patient&#39;s urinary bladder. Two catheters are sealed to the patient&#39;s two ureters and extend into the urinary bladder where they join to form one catheter. The resulting single catheter extends through the patient&#39;s urethra to the outside of the patient&#39;s body where it empties into an external urine container. A shutoff valve prevents the flow of urine from the catheter. Normal sphincter function may be lost with this device. 
     FIG. 8 is a depiction of a catheter device that is designed to fit inside a patient&#39;s urinary bladder. Two catheters are sealed to the patient&#39;s two ureters and each extends through a suprapubic incision in the patient&#39;s abdominal wall to the outside of the patient&#39;s body where both catheters empty into external urine containers. A shutoff valves prevent the flow of urine from each catheter. Normal sphincter function is maintained with this device. 
     FIG. 9 is a depiction of a catheter device that is designed to fit inside a patient&#39;s urinary bladder. Two catheters are sealed to the patient&#39;s two ureters and extend into the urinary bladder where they join to form one catheter. The resulting single catheter extends through a suprapubic incision in the patient&#39;s abdominal wall to the outside of the patient&#39;s body where it empties into an external urine container. A shutoff valve prevents the flow of urine from the catheter. Normal sphincter function is maintained with this device. 
    
    
     DESCRIPTION 
     FIG. 1 depicts a device  10  for isolating and preventing contact of urine with the urinary bladder wall  20 . Urine normally flows from the kidneys into the ureters  16 A,B, which drain into the urinary bladder  22 . Urine is held in the urinary bladder  22  until the urinary sphincter  26  relaxes, allowing urine to flow from the bladder  22  through the urethra  28  and out of the body. The device  10  prevents urine from collecting directly in the urinary bladder  22 , thus preventing contact of urine with the urinary bladder wall  20 . Isolation of urine from the urinary bladder wall  20  has therapeutic benefits in the treatment of bladder diseases, infections, and disorders. Specifically, isolating urine from the urinary bladder wall  20  allows medications within the bladder  22  to function more effectively. Isolating urine from the urinary bladder  22  also allows the urinary bladder wall  20  to be treated with medications without the medications being diluted by urine, which lessens the strength of the medication, or being flushed out of the body following the voiding of the bladder  22 , which greatly lessens the effective treatment time. Urine has a known caustic effect on cells. In a healthy urinary bladder  22 , specialized epithelial cells line the surface of the urinary bladder wall  20  and are well adapted to survive the caustic environment that urine creates. Isolating urine from the urinary bladder  22  allows epithelial cells that are damaged or are in a diseased state to better recover from disease or fight infection while in a non-caustic environment. 
     In the embodiment of the invention shown in FIG. 1, a liner  12  is designed to fit inside the urinary bladder  22 . The liner  12  is constructed from an impermeable but highly flexible and elastic material. The liner  12  forms a reservoir  13  for collecting urine therein. Such materials include vinyl, polyethylene, PVC, latex, silicone, ethylene vinyl acetate, and polypropylene. The liner  12  is constructed with two inlet orifices  14 A,B that are adapted to sealably connect to the opening of the respective ureters  16 A,B. The seals  18 A,B between the ureters  16 A,B and inlet orifices  14 A,B prevent urine from leaking into the urinary bladder  22  and insure the flow of urine into the reservoir  13  of the liner  12 . The outlet orifice  24  of the bladder liner  12  is adapted to extend into the urethra  28 , which directs the flow of urine through the urethra  28  and out of the body. The outlet orifice  24  is shown extending past the urinary sphincter  26 ; however, the outlet orifice  24  does not have to extend past the urinary sphincter  26  so long as the outlet orifice  24  is situated to prevent backflow of urine into the bladder  22 . This device allows the sphincter  26  to maintain normal function. 
     Another embodiment of the invention is shown in FIG. 2. A liner  12  is designed to fit inside the urinary bladder  22 . The liner  12  is constructed from an impermeable material. The liner  12  includes a reservoir  13  formed therein and is constructed with two inlet orifices  14 A,B that are connected directly to two inlet catheters  27 A,B. The inlet orifices  14 A,B and catheters  27 A,B may be joined by use of a fitting or any suitable bonding process. The open ends of the two catheters  27 A,B are adapted to sealably connect to the openings of the respective ureters  16 A,B. Sealing may be accomplished through mechanical means, such as the use of bioadhesive(s), o-ring(s), or soft radial fins. The seals  18 A,B are disposed between the ureters  16 A,B and input catheters  27 A,B to prevent urine from leaking into the urinary bladder  22  and insure the flow of urine into the liner  12 . An outlet catheter  29  is connected to the outlet orifice  24  of the bladder liner  12  and is adapted to extend through the urethra  28 . The outlet catheter  29  directs the flow of urine through the urethra  28  and out of the body. The outlet catheter  29  extends into the urethra  28  past the point in the urethra that is constricted by the urinary sphincter  26 . The outlet catheter  29  is composed of a material sufficiently flexible so that the catheter  29  can be completely compressed by the urinary sphincter  26 , thus preventing incontinence. 
     In an alternative embodiment shown in FIG. 3, the outlet catheter  29  of the urinary bladder liner  12  is adapted to sealably connect to the wall of the urethra  28  prior to the point in the urethra  28  that is constricted by the urinary sphincter  26 . The catheter  29  may be sealably connected by the use of bioadhesive(s) or o-ring(s)  31 . Other possible seals include radial fins, balloons, and collagen cuffs. 
     In various embodiments of the invention, the sealable connections  18 A,B,  31  may be produced by the use of at least one nonpermanent biocompatible adhesive or sealant. The adhesive forms a fluid-impermeable seal that prevents urine from entering into the urinary bladder  22 . Suitable bioadhesives include fibrin glue, cynoacrylates, and collagen cuffs. In an alternative embodiment shown in FIG. 4, the sealable connections  33 A,B between catheters  27 A,B and a luminal space in the body can be produced by the expansion of the catheters&#39; outer diameter. The expanded diameters  33 A,B of the catheters  27 A,B press against the walls of a luminal space in the body such as the ureters  16 A,B or urethra  28 . The catheters  27 A,B are held in place in the ureters  16 A,B or urethra  28  by the mechanical force exerted by the expanded ends  33 A,B of the catheters. Such a connection also provides a liquid-impermeable seal. 
     In the embodiment shown in FIGS. 5 a  and  5   b , a bladder liner  12  made from an impermeable, but highly flexible and elastic material is designed to fit inside the urinary bladder  22 . The liner  12  includes a reservoir  13  formed therein and is constructed with two catheters  35 A,B that are connected to the two inlet orifices  14 A,B of the bladder liner  12 . The catheters  35 A,B extend up the respective ureters  16 A,B and into the kidneys  48 . FIG. 5 b  depicts the ends of the catheters  35 A,B that are preformed as circular coils  44 , the purpose of which is to prevent the catheters  35 A,B from migrating down the ureters  16 A,B towards the urinary bladder  22 . The ends of the input catheters  35 A,B posses a plurality of drainage holes  42 , so urine can easily enter the catheters  35 A,B. Below (towards the urinary bladder) the drainage holes  42 , the catheters  35 A,B possess a plurality of fins  40  mounted on the exterior surfaces of the catheters  35 A,B. The fins  40  are designed to form a liquid-impermeable seal with a ureter wall. The liner  12  is also constructed with an outlet catheter  29  connected to an outlet orifice  24 . The outlet catheter  29  is adapted to extend through the urethra  28  to direct the flow of urine through the urethra  28  and out of the body. 
     In various embodiments of the invention, the urinary bladder liner  12  is constructed of a non-elastic material or a highly flexible and pliant material. A non-elastic bladder liner  12  will not expand to the dimensions of the urinary bladder  22 , and thus will not apply pressure to the urinary bladder wall  20  when the bladder liner  12  is at or near capacity. Alternatively, the liner  12  can be constructed of a highly flexible, pliant and elastic material, which allows the liner  12  to expand to the dimensions of the urinary bladder  22 . An exterior surface of the urinary bladder liner  12  may be coated with heparin or a heparin-like drug to promote the healing of the bladder wall  20  at points where the bladder wall  20  and the bladder liner  12  make contact. In addition, the exterior surface of the urinary bladder liner  12  may be coated with a slippery material such as, but not limited to, a hydrogel to reduce chafing or irritation of the bladder wall  20  at points where the bladder wall  20  and the bladder liner  12  make contact. 
     Another embodiment of a device  100  in accordance with the invention is shown in FIG.  6 . Two catheters  140 A,B are inserted into the two openings of the ureters  106 A,B in the urinary bladder  112  and are adapted to sealably connect to the ureter walls. The two catheters  140 A,B extend through the urinary bladder  112  and through the urethra  118  exiting the body. The catheters  140 A,B lead into an external collection container  144 . A valve  142  on each catheter  140 A,B functions to block the flow of urine while removing or replacing the urine collection container  144 . Alternatively, a single valve  142  may be used to isolate the flow of urine from the catheters  140 A,B to the collection container  144 . The seals  108 A,B used to seal the catheters  140 A,B to the ureter  106 A,B may be biocompatible adhesive(s), o-ring(s), fins or catheters that expand to press against the wall of the ureters  106 A,B. 
     A further embodiment of the device  100  is shown in FIG.  7 . Two catheters  140 A,B join to form a third catheter  148  in the urinary bladder  112 . The third catheter  148  extends through the urethra  118  and into an external collection container  144 . In this embodiment, only the third catheter  148  is present in the urethra  118  during the normal functioning of the apparatus, thus providing greater comfort to the patient. The third catheter  148  includes a valve  142  disposed between the distal end of the urethra  118  and the distal end of the catheter  148  that functions to block the flow of urine while removing or replacing the urine collection container  144 . The seals  108 A,B used to seal the catheters  140 A,B to the ureters  106 A,B may be biocompatible adhesive(s), o-ring(s), or catheters that expand to press against the wall of the ureters  106 A,B. The catheters  140 A,B and  148  may be joined at a catheter junction  146  by use of a fitting or bonding, or may be formed as a single assembly. The catheters  140 A,B  148  and catheter junction  146  are composed of materials comprising biocompatible plastics, such as vinyl, polyethylene, PVC, silicone, ethylene vinyl acetate, and polypropylene. 
     Yet another embodiment of a device  200  in accordance with the invention is shown in FIG.  8 . Two catheters  240 A,B are inserted into the two openings of the ureters  206 A,B in the urinary bladder  212  and are adapted to sealably connect to the ureter walls. The two catheters  240 A,B extend through the urinary bladder  112  and out of the patient&#39;s body through the bladder and abdominal walls. Specifically, the catheters  240 A,B pass through one or more suprapubic incisions  252 A,B in the patient&#39;s abdomen  250 . Generally, suprapubic incisions are incisions situated or performed superior to the patient&#39;s pubic arch. This embodiment eliminates urine drainage through the urethra  218 , thereby eliminating irritation of the urethra  218  and urinary sphincter  216  from the presence of the catheters  240 A,B. With no catheters  240 A,B present in the urethra  218 , the urinary sphincter  216  functions normally, thus providing greater comfort to the patient. Each catheter  240 A,B leads into an external collection container  244 A,B. A valve  242 A,B on each catheter  240 A,B functions to block the flow of urine while removing or replacing the urine collection container  244 A,B. 
     Alternatively, the catheters  240 A,B may pass through a single suprapubic incision  252  and connect to a single external collection container  244 . In which case, a single valve  242  may be used to isolate the flow of urine from the catheters  240 A,B to the collection container  244 . In addition, the seals  208 A,B used to seal the catheters  240 A,B to the ureter  206 A,B may be biocompatible adhesive(s), o-ring(s), fins or catheters that expand to press against the wall of the ureters  206 A,B. 
     A further embodiment of the device  200  is shown in FIG.  9 . Two catheters  240 A,B join to form a third catheter  248  in the urinary bladder  212 . The third catheter  248  extends through the patient&#39;s bladder and abdominal walls and into an external collection container  244 . Specifically, the third catheter  248  extends through a suprapubic incision  252  in the patient&#39;s abdomen  250 . This embodiment also eliminates irritation of the urethra  218  and urinary sphincter  216 , allows the urinary sphincter  216  to function normally, and provides greater comfort to the patient. The third catheter  248  includes a valve  242  disposed between the suprapubic incision  252  and the distal end of the catheter  248  that functions to block the flow of urine while removing or replacing the urine collection container  244 . Further, the seals  208 A,B used to seal the catheters  240 A,B to the ureters  206 A,B may be biocompatible adhesive(s), o-ring(s), or catheters that expand to press against the wall of the ureters  206 A,B. The catheters  240 A,B and  248  may be joined at a catheter junction  246  by use of a fitting or bonding, or may be formed as a single assembly. The catheters  240 A,B  248  and catheter junction  246  are composed of materials comprising biocompatible plastics, such as vinyl, polyethylene, PVC, silicone, ethylene vinyl acetate, and polypropylene. 
     Methods according to the invention include treating urinary bladder diseases by isolating urine from the urinary bladder wall by the use of the aforementioned devices and treating the patient with appropriate medications. Appropriate medications include oral medications comprising sodium pentosanpolysulfate, amitripyline, imipramine, hydroxyzine dihydrochloride, hydroxyzine hydrochloride, hyoscyamine sulfate, hyosyamine, oxybutynin chloride, flavoxate, urised, or phenazopyridine hydrochloride. In an alternative method, appropriate medications include topically applied medications comprising DMSO, heparin, sodium oxychlorosene, lidocaine, hydrocortisone sodium succinate, sodium bicarbonate, capsaicin, hyaluronic acid, silver nitrate, or bacillus of Calmette and Guerin (BCG). These medications are instilled between the bladder liner and bladder wall to achieve topical therapy to the inner wall of the bladder. 
     Having described certain embodiments of the invention, it will be apparent to those of ordinary skill in the art that other embodiments incorporating the concepts disclosed herein may be used without departing from the spirit and scope of the invention. The described embodiments are to be considered in all respects as only illustrative and not restrictive.